 |
|
Vitamin Supplement Use in a Low-Risk Population of US Male Physicians and Subsequent Cardiovascular Mortality
Jorg Muntwyler, MD, MPH;
Charles H. Hennekens, MD, DrPH;
JoAnn E. Manson, MD, DrPH;
Julie E. Buring, ScD;
J. Michael Gaziano, MD, MPH
Arch Intern Med. 2002;162:1472-1476.
Background Although basic research suggests that vitamins may have an important role in the prevention of cardiovascular diseases (CVD), the data from cohort studies and clinical trials are inconclusive.
Methods This prospective cohort study was conducted among 83 639 male physicians residing in the United States who had no history of CVD or cancer. At baseline, data on use of vitamin E, ascorbic acid (vitamin C), and multivitamin supplements were provided by a self-administered questionnaire. Mortality from CVD and coronary heart disease (CHD) was assessed by death certificate review.
Results Use of supplements was reported by 29% of the participants. During a mean follow-up of 5.5 years, 1037 CVD deaths occurred, including 608 CHD deaths. After adjustment for several cardiovascular risk factors, supplement use was not significantly associated with total CVD or CHD mortality. For vitamin E use, the relative risks (RRs) were 0.92 (95% confidence interval [CI], 0.70-1.21) for total CVD mortality and 0.88 (95% CI, 0.61-1.27) for CHD mortality; for use of vitamin C, the RRs were 0.88 (95% CI, 0.70-1.12) for total CVD mortality and 0.86 (95% CI, 0.63-1.18) for CHD mortality; and for use of multivitamin supplements, the RRs were 1.07 (95% CI, 0.91-1.25) for total CVD mortality and 1.02 (95% CI, 0.83-1.25) for CHD mortality.
Conclusions In this large cohort of apparently healthy US male physicians, self-selected supplementation with vitamin E, vitamin C, or multivitamins was not associated with a significant decrease in total CVD or CHD mortality. Data from ongoing large randomized trials will be necessary to definitely establish small potential benefits of vitamin supplements on subsequent cardiovascular risk.
From the Department of Internal Medicine, University Hospital of Zurich, Zurich, Switzerland (Dr Muntwyler); University of Miami School of Medicine, Miami, Fla (Dr Hennekens); and Division of Preventive Medicine (Drs Manson, Buring, and Gaziano) and Cardiovascular Division (Dr Gaziano), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; Department of Ambulatory Care and Prevention, Harvard Medical School (Dr Buring); Department of Epidemiology, Harvard School of Public Health (Drs Manson and Buring); and the Massachusetts Veterans Epidemiology Research and Information Center, Boston Veterans Affairs Healthcare System (Dr Gaziano), Boston, Mass.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Dietary patterns and 15-y risks of major coronary events, diabetes, and mortality
Brunner et al.
Am. J. Clin. Nutr. 2008;87:1414-1421.
ABSTRACT
| FULL TEXT
Egg consumption in relation to cardiovascular disease and mortality: the Physicians' Health Study
Djousse and Gaziano
Am. J. Clin. Nutr. 2008;87:964-969.
ABSTRACT
| FULL TEXT
New Developments and Novel Therapeutic Perspectives for Vitamin C
Li and Schellhorn
J. Nutr. 2007;137:2171-2184.
ABSTRACT
| FULL TEXT
Multivitamin Use and Risk of Prostate Cancer in the National Institutes of Health-AARP Diet and Health Study
Lawson et al.
JNCI J Natl Cancer Inst 2007;99:754-764.
ABSTRACT
| FULL TEXT
Heart disease and single-vitamin supplementation
Traber
Am. J. Clin. Nutr. 2007;85:293S-299S.
ABSTRACT
| FULL TEXT
Clinical trials and observational studies to assess the chronic disease benefits and risks of multivitamin-multimineral supplements
Prentice
Am. J. Clin. Nutr. 2007;85:308S-313S.
ABSTRACT
| FULL TEXT
Brief Communication: The Prevalence of High Intake of Vitamin E from the Use of Supplements among U.S. Adults
Ford et al.
ANN INTERN MED 2005;143:116-120.
ABSTRACT
| FULL TEXT
Low Total Vitamin C Plasma Level Is a Risk Factor for Cardiovascular Morbidity and Mortality in Hemodialysis Patients
Deicher et al.
J. Am. Soc. Nephrol. 2005;16:1811-1818.
ABSTRACT
| FULL TEXT
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller et al.
ANN INTERN MED 2005;142:37-46.
ABSTRACT
| FULL TEXT
Vitamin E Supplements: Good in Theory, but Is the Theory Good?
Greenberg
ANN INTERN MED 2005;142:75-76.
FULL TEXT
Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts
Knekt et al.
Am. J. Clin. Nutr. 2004;80:1508-1520.
ABSTRACT
| FULL TEXT
Commentary: Vitamin supplement use and confounding by lifestyle
Hoggatt
Int J Epidemiol 2003;32:553-555.
FULL TEXT
Multivitamin Supplements Are Inversely Associated with Risk of Myocardial Infarction in Men and Women--Stockholm Heart Epidemiology Program (SHEEP)
Holmquist et al.
J. Nutr. 2003;133:2650-2654.
ABSTRACT
| FULL TEXT
Routine Vitamin Supplementation To Prevent Cancer and Cardiovascular Disease: Recommendations and Rationale
U.S. Preventive Services Task Force*
ANN INTERN MED 2003;139:51-55.
ABSTRACT
| FULL TEXT
Routine Vitamin Supplementation To Prevent Cardiovascular Disease: A Summary of the Evidence for the U.S. Preventive Services Task Force
Morris and Carson
ANN INTERN MED 2003;139:56-70.
ABSTRACT
| FULL TEXT
Diets and Clinical Coronary Events: The Truth Is Out There
Yancy et al.
Circulation 2003;107:10-16.
FULL TEXT
Combined Vitamin E and Vitamin C Supplement Use and Risk of Cardiovascular Disease Mortality
Simon et al.
Arch Intern Med 2002;162:2630-2630.
FULL TEXT
Cardiovascular highlights from non-cardiology journals
Malik
Heart 2002;88:439-440.
FULL TEXT
|
